Clear Search

From Research to Results

Our Impact

We invest in research that’s changing how we think about cancer. That means more answers, faster breakthroughs, and personalized treatment for every patient. With more than a billion dollars raised to fuel our mission, that’s progress. This year, BCRF is the largest private funder of breast cancer research—and the largest private funder of metastatic research—in the U.S.

The Ground We've Gained

Research is revolutionizing our understanding of breast cancer and bringing us closer to a cure. Discover how far science has come since BCRF’s founding in 1993—and how our investigators have been involved in every major breakthrough.

timeline

SEE THE TIMELINE

We Fund the Best Researchers in the World

Meet the Game Changers

Today, we support more than 260 scientists making a real difference and accelerating progress. Get to know them and learn about their projects.

OUR APPROACH FIND A RESEARCHER

Our Areas of Focus

Breast cancer is a complex disease with no simple solution, which is why our researchers are tackling it from every angle. Learn about our areas of focus and why each is critical to knowing how to fight cancer from the start, slow its progress and one day stop it from occurring altogether.

Heredity & Ethnicity

Most people who develop breast cancer have no family history of the disease, but we know that’s not always the case. A person’s family history, inheritance, race and ethnicity are all important risk factors that have long been part of our research agenda. Our scientists have been behind major breakthroughs in this area, including discovering the role BRCA1 and BRCA2 play in breast cancer and uncovering the genetic link to more aggressive forms of the disease in women of African descent. The more progress our researchers make, the better doctors are able to predict who is at risk and what can be done to prevent cancer’s onset.

READ MORE

Heredity & Ethnicity Researchers

Susan Kesmodel, MD

Titles and Affiliations Director of Breast Surgical Oncology Co-Leader of Breast Site Disease Group...

BCRF Investigator Since

2024

Ying Ni, PhD

Titles and Affiliations Assistant Professor Cleveland Clinic Lerner College of Medicine Assistant Staff Member,...

BCRF Investigator Since

2024

Shani Paluch-Shimon, MBBS

Titles and Affiliations Director of Breast Oncology, Sharett Institute of Oncology Co-Director of the...

BCRF Investigator Since

2024

Melissa Troester, PhD, MPH

Titles and Affiliations Professor, Epidemiology and Pathology & Lab Medicine Director, Center for Environmental...

BCRF Investigator Since

2023

Celeste Leigh Pearce, PhD, MPH

Titles and Affiliations Professor, Department of Epidemiology, School of Public Health Rogel Scholar and...

BCRF Investigator Since

2023

Julie Palmer, ScD

Titles and Affiliations Karin Grunebaum Professor in Cancer Research, Hematology/Oncology, Department of Medicine Director,...

BCRF Investigator Since

2023

Terry Hyslop, PhD

Titles and Affiliations Professor, Department of Pharmacology, Physiology, and Cancer Biology Director, Center for...

BCRF Investigator Since

2023

Elisa Bandera, MD, PhD

Titles and Affiliations Professor and Chief of Cancer Epidemiology Co-Leader, Cancer Prevention and Control...

BCRF Investigator Since

2023

Veronica Jones, MD, FACS

Titles and Affiliations Assistant Professor, Division of Breast Surgery, Department of Surgery and Division...

BCRF Investigator Since

2023

Jeffrey Weitzel, MD

Titles and Affiliations Director, Division of Precision Prevention Department of Internal Medicine Research area...

BCRF Investigator Since

2023

Collaborative Initiatives

Impactful breast cancer research isn’t siloed. BCRF helps power several large, multi-year research efforts across institutions and industries.

LEARN MORE